US FDA Opens Door For J&J's Spravato To Another MDD Population

 
• By Jessica Merrill
  
depressed Women sitting head in hands on the bed in the dark bedroom with low light environment, dramatic concept
J&J's Spravato is approved for a new depression indication • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category